denovoMATRIX receives seed financing

13-Dec-2018 - Germany

denovoMATRIX develops and manufactures biomimetic coatings for stem cell culture. With its technology, the team of denovoMATRIX enables cutting edge research in the stem cell field, and aims to revolutionize cell culture processes in Life Science research. The HTGF together with TGFS are participating in the seed financing round to support the growing denovoMATRIX team, and the launch of denovoMATRIX products into the market.

In recent months, denovoMATRIX has received great feedback and support from industry experts, winning the Innovation prize from IQ-Mitteldeutschland Life Science Cluster. ‘’Although we are pleased with our performance at various businessplan competitions, we are currently focusing our attention on our myMATRIX product line, designed for streamlining cell culture processes using defined, serum-free conditions’’ explains the CEO of denovoMATRIX, Dejan Husman. The start-up already has their first product line – the screenMATRIX – available for purchase through their website. It is a tool designed for researchers interested in discovering the ideal conditions for culturing their cells.

Dr. Fabian Mohr, Investment Manager at HTGF: “In order to be able to offer high-quality stem cell therapies in the future, manufacturers must keep their variability in cell cultivation low. denovoMATRIX products offer a chemically defined solution to this problem, which we hope will provide a good basis for the translation of stem cell therapies from research into clinical practice.”

Other news from the department business & finance

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance

Something is happening in the life science industry ...

This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.